Histone deacetylase inhibitor sodium butyrate regulates the activation of toll-like receptor 4/interferon regulatory factor-3 signaling pathways in prostate cancer cells. - Ozkan, Asuman; Eskiler, Gamze; Kazan, Nur; Turna, Ozge (Journal of Cancer Research & Therapeutics, 2023)